Inactive Provider
This provider's NPI has been deactivated on 04/21/2026. The information on this page is historical and may no longer be current.
Total Payments
$18,790
2024 Payments
$2,163
Companies
64
Transactions
1,369
Medicare Patients
8,548
Medicare Billing
$805,423
Payment Breakdown by Category
Food & Beverage$18,569 (98.8%)
Education$220.96 (1.2%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $18,569 | 1,363 | 98.8% |
| Education | $220.96 | 6 | 1.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $2,983 | 232 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $1,830 | 117 | $0 (2024) |
| Amgen Inc. | $1,707 | 109 | $0 (2024) |
| GlaxoSmithKline, LLC. | $1,145 | 104 | $0 (2024) |
| Lilly USA, LLC | $1,063 | 87 | $0 (2024) |
| ABBVIE INC. | $1,003 | 79 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $981.69 | 65 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $719.43 | 63 | $0 (2024) |
| Merck Sharp & Dohme LLC | $701.55 | 64 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $621.24 | 37 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,163 | 136 | Novo Nordisk Inc ($379.51) |
| 2023 | $1,900 | 122 | AbbVie Inc. ($328.91) |
| 2022 | $2,353 | 168 | Novo Nordisk Inc ($302.60) |
| 2021 | $2,537 | 177 | Novo Nordisk Inc ($591.93) |
| 2020 | $1,938 | 144 | Novo Nordisk Inc ($326.04) |
| 2019 | $2,523 | 200 | Novo Nordisk Inc ($399.53) |
| 2018 | $2,712 | 199 | Novo Nordisk Inc ($517.30) |
| 2017 | $2,664 | 223 | AstraZeneca Pharmaceuticals LP ($376.00) |
All Payment Transactions
1,369 individual payment records from CMS Open Payments — Page 1 of 55
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $11.11 | General |
| Category: Inflammation | ||||||
| 12/17/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $17.55 | General |
| Category: RESPIRATORY | ||||||
| 12/13/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $19.51 | General |
| Category: Endocrinology | ||||||
| 12/12/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $18.99 | General |
| Category: Bone Health | ||||||
| 12/10/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $16.31 | General |
| Category: Inflammation | ||||||
| 12/09/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $18.44 | General |
| Category: PAIN | ||||||
| 11/25/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $17.21 | General |
| Category: Inflammation | ||||||
| 11/19/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $25.11 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 11/12/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $23.94 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/11/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $17.79 | General |
| Category: DIABETES | ||||||
| 11/08/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $20.81 | General |
| Category: Endocrinology | ||||||
| 11/07/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $16.09 | General |
| Category: VACCINES | ||||||
| 11/04/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $24.86 | General |
| Category: Obesity | ||||||
| 10/31/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $14.07 | General |
| Category: Oncology | ||||||
| 10/30/2024 | GlaxoSmithKline, LLC. | SHINGRIX (Biological), AREXVY | Food and Beverage | In-kind items and services | $15.12 | General |
| Category: VACCINES | ||||||
| 10/29/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $17.78 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/28/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $22.14 | General |
| Category: NEUROSCIENCE | ||||||
| 10/28/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $6.29 | General |
| Category: Diabetes | ||||||
| 10/23/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $24.34 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/21/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $20.78 | General |
| Category: Diabetes | ||||||
| 10/19/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $8.40 | General |
| Category: Diabetes | ||||||
| 10/17/2024 | Boston Scientific Corporation | WaveWriter Alpha Prime 16 (Device) | Food and Beverage | In-kind items and services | $31.10 | General |
| Category: WaveWriter Alpha_NMD | ||||||
| 10/10/2024 | IDORSIA PHARMACEUTICALS US INC | QUVIVIQ (Drug) | Food and Beverage | In-kind items and services | $15.91 | General |
| Category: Insomnia | ||||||
| 10/10/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $14.12 | General |
| Category: Diabetes | ||||||
| 10/09/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $17.85 | General |
| Category: Diabetes | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 14 | 1,637 | 2,059 | $697,474 | $169,623 |
| 2022 | 18 | 2,039 | 2,516 | $603,602 | $203,788 |
| 2021 | 16 | 2,172 | 2,627 | $488,226 | $199,386 |
| 2020 | 16 | 2,700 | 3,925 | $633,556 | $232,625 |
Total Patients
8,548
Total Services
11,127
Medicare Billing
$805,423
Procedure Codes
64
All Medicare Procedures & Services
64 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 610 | 964 | $356,680 | $75,021 | 21.0% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 463 | 463 | $183,811 | $56,960 | 31.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 240 | 285 | $72,105 | $15,585 | 21.6% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 45 | 45 | $49,275 | $12,686 | 25.7% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2023 | 14 | 14 | $7,952 | $2,221 | 27.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 17 | 17 | $9,537 | $1,685 | 17.7% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 49 | 49 | $2,793 | $1,423 | 50.9% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 16 | 16 | $3,504 | $1,147 | 32.7% |
| 87428 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus and influenza | Office | 2023 | 15 | 16 | $4,074 | $857.99 | 21.1% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 93 | 93 | $2,139 | $774.31 | 36.2% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 16 | 16 | $912.00 | $486.67 | 53.4% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 11 | 33 | $2,277 | $330.15 | 14.5% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 33 | 33 | $1,320 | $304.64 | 23.1% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 15 | 15 | $1,095 | $140.76 | 12.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 643 | 1,049 | $294,866 | $83,674 | 28.4% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 525 | 525 | $141,455 | $65,361 | 46.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 248 | 292 | $55,716 | $14,921 | 26.8% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 128 | 130 | $19,835 | $8,298 | 41.8% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2022 | 23 | 23 | $22,329 | $6,396 | 28.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 44 | 44 | $19,276 | $4,471 | 23.2% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2022 | 24 | 24 | $8,768 | $3,853 | 43.9% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 128 | 130 | $6,530 | $3,535 | 54.1% |
| 90732 | Pneumococcal vaccine, 23-valent | Office | 2022 | 25 | 25 | $4,445 | $3,287 | 74.0% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2022 | 11 | 11 | $7,227 | $2,129 | 29.5% |
| 99495 | Transitional care management services for problem of moderate complexity | Office | 2022 | 12 | 12 | $5,332 | $1,879 | 35.2% |
About Dr. Daniel Boone, M.D
Dr. Daniel Boone, M.D is a Internal Medicine healthcare provider based in Evans, Georgia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/07/2006. The National Provider Identifier (NPI) number assigned to this provider is 1225131998.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Daniel Boone, M.D has received a total of $18,790 in payments from pharmaceutical and medical device companies, with $2,163 received in 2024. These payments were reported across 1,369 transactions from 64 companies. The most common payment nature is "Food and Beverage" ($18,569).
As a Medicare-enrolled provider, Boone has provided services to 8,548 Medicare beneficiaries, totaling 11,127 services with total Medicare billing of $805,423. Data is available for 4 years (2020–2023), covering 64 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Location Evans, GA
- Active Since 09/07/2006
- Last Updated 09/10/2018
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1225131998
Products in Payments
- FARXIGA (Drug) $1,319
- Ozempic (Drug) $1,098
- Saxenda (Drug) $773.10
- JARDIANCE (Drug) $722.96
- VRAYLAR (Drug) $653.98
- Vascepa (Drug) $542.57
- JANUVIA (Drug) $508.31
- TRULICITY (Drug) $458.21
- TRELEGY ELLIPTA (Drug) $440.44
- MOUNJARO (Drug) $436.87
- XARELTO (Drug) $428.11
- Otezla (Drug) $391.77
- LEQVIO (Drug) $373.63
- Victoza (Drug) $368.33
- Aimovig (Biological) $353.99
- EVENITY (Biological) $352.64
- XIFAXAN (Drug) $352.17
- UBRELVY (Drug) $349.44
- Repatha (Biological) $344.73
- Kerendia (Drug) $288.24
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Evans
Christopher Mcelroy, M.d, M.D
Internal Medicine — Payments: $88,428
Internal Medicine $88,428
Mr. Christopher Henson, M.d, M.D
Internal Medicine — Payments: $20,721
Internal Medicine $20,721
Dr. Barry Tarpley, M.d, M.D
Internal Medicine — Payments: $12,552
Internal Medicine $12,552
Dr. Zhenrong Zhang, M.d, M.D
Internal Medicine — Payments: $5,886
Internal Medicine $5,886
Dr. Robert West, M.d, M.D
Internal Medicine — Payments: $4,285
Internal Medicine $4,285
Mr. Connor Gilbert, Np, NP
Internal Medicine — Payments: $2,266
Internal Medicine $2,266